Impact of anti-CD20 monoclonal antibodies on serologic response to
Por um escritor misterioso
Descrição
Building better monoclonal antibody-based therapeutics
JCI Insight - Prior cycles of anti-CD20 antibodies affect antibody responses after repeated SARS-CoV-2 mRNA vaccination
Synergistic anti-tumor therapy by a comb-like multifunctional antibody nanoarray with exceptionally potent activity
Full article: Effect of FcRn antagonism on protective antibodies and to vaccines in IgG-mediated autoimmune diseases pemphigus and generalised myasthenia gravis
Overview of therapeutic monoclonal antibodies - UpToDate
Full article: Anti-CD20 treatment for B-cell malignancies: current status and future directions
Vaccines, Free Full-Text
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives
Anti-CD20 antibodies and bendamustine attenuate humoral immunity to COVID-19 vaccination in patients with B-cell non-Hodgkin lymphoma
Frontiers IgG4 Autoantibodies in Organ-Specific Autoimmunopathies: Reviewing Class Switching, Antibody-Producing Cells, and Specific Immunotherapies
Frontiers Impact of Depleting Therapeutic Monoclonal Antibodies on the Host Adaptive Immunity: A Bonus or a Malus?
Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients - ScienceDirect
Anti-CD20 antibodies and bendamustine attenuate humoral immunity to COVID-19 vaccination in patients with B-cell non-Hodgkin lymphoma
de
por adulto (o preço varia de acordo com o tamanho do grupo)
_20140516.jpg)
